PEN - Penumbra, Inc.
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, and PX SLIM brands.
As of May 15, 2026: spot at $322.73, ATM IV 46.1%, max pain $340.00, net GEX -$1.5M.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Market Cap
- $12.69B
- P/E Ratio
- 74.07
- Beta
- 0.73
- 52-Week Range
- 221.26-362.41
- CEO
- Adam Elsesser
- Employees
- 4,500
- IPO Date
- Sep 18, 2015
- Exchange
- NYSE
What PEN Looks Like to Options Traders Today
IV rank of 9.1% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); negative net gamma exposure (-$1.5M) means dealers hedge with trend, amplifying realized volatility and accelerating directional moves; the 25-delta skew (-0.004) is roughly flat across the wings.
What This Page Covers
The PEN overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked PEN overview questions
- What is PEN?
- PEN is the ticker symbol for Penumbra, Inc., a listed security. Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. Listed on NYSE. PEN is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the PEN options snapshot look like today?
- As of May 15, 2026, the PEN options snapshot shows spot at $322.73, ATM IV 46.1%, IV rank 9.1%, max pain $340.00, net GEX -$1.5M, expected move 13.22%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are PEN's key statistics?
- Penumbra, Inc. (PEN) carries a market capitalization of $12.69B, trailing P/E ratio of 74.07, beta of 0.73 relative to the broader market, 52-week range of 221.26-362.41. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does PEN belong to?
- Penumbra, Inc. operates in the Healthcare sector, in the Medical - Devices industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare PEN's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the PEN data on this page?
- The options snapshot above is dated May 15, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).